Aspirin, acetaminophen and proton transport through phospholipid bilayers and mitochondrial membranes.
Mechanisms of proton transport were investigated in planar phospholipid bilayer membranes exposed to aspirin (acetylsalicylic acid), acetaminophen (4-acetamidophenol), benzoic acid and three aspirin metabolites (salicylic acid, gentisic acid and salicyluric acid). The objectives were to characterize the conductances and permeabilities of these weak acids in lipid bilayer membranes and then predict their effects on mitochondrial membranes. Of the compounds tested only aspirin, benzoate and salicylate caused significant increases in membrane conductance. The conductance was due mainly to proton current at low pH and to weak acid anion current at neutral pH. Analysis of the concentration and pH dependence suggests that these weak acids act as HA-2-type proton carriers when pH approximately pK and as lipid soluble anions at neutral pH. Salicylate is much more potent than aspirin and benzoate because salicylate contains an internal hydrogen bond which delocalizes the negative charge and increases the permeability of the anion. Model calculations for mitochondria suggest that salicylate causes net H+ uptake by a cyclic process of HA influx and A- efflux. This model can explain the salicylate-induced uncoupling and swelling observed in isolated mitochondria. Since ingested aspirin breaks down rapidly to form salicylate, these results may clarify the mechanisms of aspirin toxicity in humans. The results may also help to explain why the ingestion of aspirin but not acetaminophen is associated with Reye's syndrome, a disease characterized by impaired energy metabolism and mitochondrial swelling.
Gutknecht
J
J
Department of Cell Biology, Duke University Medical Center, Beaufort, North Carolina.
D000082:Acetaminophen / Q000494:pharmacology*; D000818:Animals; D000838:Anions; D001241:Aspirin / Q000494:pharmacology* / Q000506:poisoning; D001692:Biological Transport / Q000187:drug effects; D006801:Humans; D006863:Hydrogen-Ion Concentration; D007425:Intracellular Membranes / Q000187:drug effects*; D008051:Lipid Bilayers / Q000737:chemistry; D008928:Mitochondria / Q000187:drug effects*; D010085:Oxidative Phosphorylation / Q000187:drug effects; D010539:Permeability; D010743:Phospholipids / Q000737:chemistry; D011522:Protons; D012202:Reye Syndrome / Q000503:physiopathology; D012459:Salicylates / Q000494:pharmacology; D020156:Salicylic Acid; D014475:Uncoupling Agents
D000838:Anions; D008051:Lipid Bilayers; D010743:Phospholipids; D011522:Protons; D012459:Salicylates; D014475:Uncoupling Agents; D000082:Acetaminophen; D020156:Salicylic Acid; D001241:Aspirin